ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 129 filers reported holding ALLAKOS INC in Q1 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $533 | -60.6% | 235 | -24.2% | 0.00% | – |
| Q2 2023 | $1,352 | +135100.0% | 310 | +31.9% | 0.00% | – |
| Q1 2023 | $1 | -50.0% | 235 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 235 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 235 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -93.3% | 235 | -91.1% | 0.00% | – |
| Q1 2022 | $15,000 | +15.4% | 2,635 | +42.2% | 0.00% | – |
| Q4 2021 | $13,000 | -94.5% | 1,853 | -17.1% | 0.00% | -100.0% |
| Q3 2021 | $237,000 | +182.1% | 2,235 | +126.9% | 0.00% | 0.0% |
| Q2 2021 | $84,000 | -25.7% | 985 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $113,000 | -18.1% | 985 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $138,000 | +91.7% | 985 | +11.3% | 0.00% | 0.0% |
| Q3 2020 | $72,000 | +33.3% | 885 | +17.4% | 0.00% | – |
| Q2 2020 | $54,000 | +31.7% | 754 | -17.7% | 0.00% | – |
| Q1 2020 | $41,000 | -50.6% | 916 | +5.8% | 0.00% | -100.0% |
| Q4 2019 | $83,000 | – | 866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |